Earnings calls / RNFI · August 10, 2026

RNFI Services Ltd Q1 FY27 Earnings Call Summary

Q1 FY27 revenue rose 8% YoY, but reported PBT fell because of deliberate hiring, telemarketing and leadership investments; adjusted for these, PBT grew about ₹4 crores. The real driver is diversification into insurance with ₹15 crores quarterly revenue versus ₹24 crores for last full year, plus delinquency collections and PaySprint. Management reaffirmed 40-50% FY27 PAT growth guidance, saying Q2 improves and Q3-Q4 sees a very big leap. Main risk is regulatory churn, with AEPS FaceAuth paused and Sahayak count down 10% versus industry 8%, plus forex margins swinging to a ₹17.57 crore loss.

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives

2 Deepankar Agarwal, Sameer Nagpal

Analysts

4 Daishwary Raviraj, Dheeraj Jain, Harsh Mulchandani, Harshad Shah

Financials & KPIs

Metric Reported Commentary
Revenue Growth +8% YoY Moderate; DMT and PPI-assisted AEPS products declined, offset by insurance and delinquency growth
Gross Profit Growth +15% YoY Before growth investments; adjusted for investments, grew ~₹2.5 crores
PBT (Adjusted for investments) +₹4 crores Would have been in line with guided trajectory absent growth investments across direct/indirect costs
Insurance Revenue ₹15 crores Strong scale-up despite seasonally slow Q1; insurance and delinquency are key high-margin growth engines
Insurance Segment Revenue ~3x YoY; Profit ₹163.17 vs ₹113.20 (+51%) Fresh ground hiring and telemarketing setup in Q1 temporarily compressed segment margins
Forex Segment Revenue +5% YoY; PBT ₹-17.57 vs ₹27.14 Volumes held on dollar strength, but global economic conditions squeezed margins substantially
Sahayak Network -10% QoQ (industry -8%) Regulatory churn from AEPS FaceAuth pause and L1 device investment; multi-product adoption (3-4 products per Sahayak) rising, showing stickiness
ARPU Declined (network consolidation) Driven by count reduction; management targets normalization to ₹1,200-1,500 as product cross-sell deepens

Geographic & Segment Commentary

  • BC/Payment Business (AEPS, DMT, PPI-assisted DMT): Core transactional vertical faced regulatory headwinds — AEPS FaceAuth was enabled in Q4 FY26 but paused by NPCI after 45 days, and a new OTP requirement was introduced for withdrawals above ₹5,000. Product diversification (UPI cash withdrawal, CMS, CRA) is partially offsetting these disruptions.

  • Insurance & Delinquent Loan Collection: Both high-margin "blue ocean" engines clocked strong growth despite a seasonally slow Q1 for the industry. Insurance revenue hit ₹15 crores in Q1 vs ₹24 crores for the full previous year, signaling a dramatic run-rate acceleration. Delinquency collections also grew substantially and is expected to scale further in H2.

  • PaySprint (B2B API/SaaS): The payment orchestration platform, built on AI-led architecture, continues to perform well and is expected to contribute significantly over the next three quarters. It serves as a key diversification lever for the group.

  • Forex/Remittance: Revenue grew ~5% on dollar strength, but margins compressed sharply. The remittance platform integration with banks is near completion, but management is deliberately deferring scale-up until global economic conditions stabilize.

  • CRA / Mutual Fund Distribution: Secured a tie-up with a large private sector bank for CRA arrangement; asset distribution to commence at the backend of Q2 or early Q3. Mutual fund distribution is slated to go live late Q2/early Q3, initially targeting Sahayaks.

Company-Specific & Strategic Commentary

  • Growth Investment Thesis: Management consciously invested in Q1 across manpower, distribution, insurance (telemarketing setup), delinquency collections, and leadership hiring (COO joined July 2026). These costs sit across direct and indirect line items, temporarily depressing PAT/EBITDA, but are expected to yield results from H2 onwards.

  • Product Diversification (Blue Ocean Focus): Strategy is to reduce dependence on regulated red-ocean products (AEPS, DMT) by scaling insurance, delinquent loan collection, UPI cash withdrawal, prepaid instruments, and foreign remittances. No single product or segment contributes more than 9% of PBT.

  • Strategic Partnerships: Recently entered a partnership with Yatra.com for travel network; PayWorld acquisition is in final phase of RBI queries on change of control (smart payment/PPI license), with Mooney/PPI products expected to go live once approved.

  • AI-Led Transformation: Using AI across product development (faster turnaround), sales automation (paperless sales organization tool launching in weeks), fraud prevention/FRM tools, and vernacular training modules for Sahayaks. Regional L&D setup planned for multi-product training.

Guidance & Outlook

Metric Guidance / Outlook Commentary
PAT Growth (FY27) 40-50% YoY (committed) Management reaffirmed full-year guidance; Q1 investments were factored in when guiding. Q2 will be better than Q1, with a "very big leap" in Q3-Q4
Revenue Trajectory Q3-Q4 substantial acceleration Driven by insurance, delinquency, and PaySprint scale-up; newly hired leadership and ground teams to drive cross-sell
ARPU ₹1,200-1,500 (normalized) Expected as regulatory ambiguity clears, consolidation happens in the industry, and multi-product adoption deepens
Insurance Vertical Ambitious growth targeted (no formal guidance) Management confident of scaling on cost efficiency and network reach, but declined to commit to specific run-rate targets
PayWorld / PPI Products Go-live post-RBI approval (near-term) In last phase of RBI queries; products (Mooney, PPI) will scale rapidly once live

Risks & Constraints

Risk Context
Regulatory Disruption (AEPS/DMT) AEPS FaceAuth was paused by NPCI 45 days after launch; new OTP mandate for withdrawals >₹5,000 added friction. Product maturity means recurring regulatory changes are expected — management plans to insulate via diversification but near-term revenue drag persists
Sahayak Network Churn Network down 10% vs industry 8% due to regulatory consolidation; part-time Sahayaks exited as L1 device economics turned unattractive. Multi-product Sahayaks (3-4 products) increased, indicating higher quality but lower absolute count
Investment Payoff Timing Q1-Q2 heavy investments (manpower, telemarketing, leadership, L&D) may take longer to translate into profitability. Management is confident of H2 results but flagged continued Q2 investment (fresh hiring), creating near-term margin pressure
Forex/Remittance Exposure Global economic conditions compressed forex margins despite revenue growth; remittance scale-up deliberately deferred pending stability, delaying a Phase 2 growth engine
Competitive/Industry Slowdown Q1 industry BC/payment volumes declined (8%), with AEPS and DMT product headwinds continuing. Consolidation opportunity exists, but timing is uncertain

Q&A Highlights

PAT Growth Guidance Commitment

  • Question: We guided 40-50% PAT growth for FY27 — does Q1's weaker print put that at risk? Will growth reflect from Q2 itself? (Daishwary Raviraj)
  • Answer: Investments were already factored into the guidance. Q1 and Q2 will see muted growth, but Q3-Q4 will see a very big leap. Adjusted for investments, PBT grew ~₹4 crores in Q1, so underlying trajectory is on track. FY28 will benefit from the foundation laid this year. Insurance revenue of ₹15 crores in Q1 (vs ₹24 crores full-year last year) and delinquency growth demonstrate momentum. (Deepankar Agarwal; Sameer Nagpal)

Forex Segment Margin Decline

  • Question: Forex revenue is up 5% but segment PBT swung from ₹27.14 to -₹17.57. What happened? (Harshad Shah)
  • Answer: The BC/high-volume low-margin business slowed, and global economic conditions (dollar strength) lifted volumes but crushed margins. Management sees consolidation opportunity in this segment going forward. (Sameer Nagpal)

Insurance Segment Profit vs Revenue Gap

  • Question: Insurance revenue is up 3x but profits only up 50%. Is there pressure? (Harshad Shah)
  • Answer: We are hiring on the ground and investing in the insurance cost segment — these are growth investments. Q2 will see additional investment that pays off in Q3-Q4; margins will improve as the distribution scale builds. (Deepankar Agarwal)

Revenue Flattish, Volatile Profits

  • Question: Revenue has barely grown for a couple of quarters and margins are volatile — how should we read the trends? (Dheeraj Jain)
  • Answer: DMT and AEPS products declined, but insurance, delinquency, forex, CRA, and CMS have filled the gap — that's the benefit of diversification. No product contributes more than 9% of PBT. High-margin verticals (insurance, delinquency, PaySprint) are growing fast and will normalize overall optics in coming quarters. (Deepankar Agarwal; Sameer Nagpal)

ARPU Slowdown & Sustainable Growth

  • Question: Why is ARPU growth slow if cross-sell is the strategy? What is sustainable ARPU? (Dheeraj Jain)
  • Answer: Regulatory changes caused agent churn (L1 device economics broke for part-time Sahayaks). With regulatory clarity emerging, consolidation will improve ARPU — expected to climb from current levels to ₹1,200-1,500. (Deepankar Agarwal)

PayWorld Acquisition Status

  • Question: What are the deliverables from the PayWorld acquisition? (Dheeraj Jain)
  • Answer: RBI queries on change of control are in the final phase — outcome expected soon. Once approved, Mooney (PPI) products will scale rapidly. PayWorld's travel network is performing well and will support forex and remittance growth. PayWorld is currently at break-even. (Deepankar Agarwal)

Q1 Major Costs (One-off or Recurring?)

  • Question: What were the major Q1 costs — any one-offs? Will Q2 also carry these? (Dheeraj Jain)
  • Answer: On-ground employees for delinquency/distribution, insurance telemarketing setup, and leadership hires (COO joined July 2026) are the major costs. These are growth investments — Q2 will see further leadership and L&D investment; not one-offs. (Deepankar Agarwal; Sameer Nagpal)

AI Utilization & Impact

  • Question: How is AI being used across cost, time, lead, and reach? (Dheeraj Jain)
  • Answer: AI is used in product development (faster turnaround), an AI-driven payment orchestration platform (negligible marginal cost for SMEs), in-house sales automation tool (launching in weeks for a paperless sales org), fraud prevention/FRM tools, and vernacular training modules for Sahayaks. (Deepankar Agarwal; Sameer Nagpal)

Sahayak Growth & Stickiness

  • Question: Sahayak count has not shown lucrative growth — what about retention/stickiness? (Dheeraj Jain)
  • Answer: AEPS FaceAuth was enabled in Q4 FY26 but paused by NPCI after 45 days — a major industry disruption. Count hasn't jumped, but the consolidation is heartening: more Sahayaks now sell 3-4 products, showing long-term stickiness. Industry is set for consolidation; players invested ahead will benefit. (Sameer Nagpal)

Slow-Growing Segments & Insurance Run-Rate

  • Question: Which segments are structurally slow vs seasonal? Can insurance hit ₹100 crores this year? (Harsh Mulchandani)
  • Answer: Only the BC/payment business (DMT, PPI-assisted DMT, AEPS) is slow — structural changes from discontinued products. Everything else is on track. AEPS is a mature product that will keep seeing regulatory ripples; UPI cash withdrawal is a complementary product providing growth. On ₹100 crores insurance — management declined to give specific guidance but committed to scaling the business strongly. (Deepankar Agarwal; Sameer Nagpal)

Insurance Mix (Life vs General)

  • Question: Is the insurance business predominantly life or general? (Harsh Mulchandani)
  • Answer: Currently mixed; health insurance to be added gradually. (Deepankar Agarwal)

Key Takeaway

RNFI Services delivered a muted Q1 FY27 headline, with revenue growing ~8% YoY and reported PBT/EBITDA hit by deliberate growth investments across direct and indirect cost lines — adjusted for these, PBT would have grown ~₹4 crores and gross profit ~₹2.5 crores. The strategy is to invest ahead in high-margin "blue ocean" engines: insurance clocked ₹15 crores in Q1 (vs ₹24 crores full-year last year), delinquent loan collections scaled substantially, and the AI-led PaySprint orchestration platform is expected to contribute meaningfully over the next three quarters. Management reaffirmed the 40-50% FY27 PAT growth guidance, positioning Q2 as a recovery quarter with a "very big leap" in Q3-Q4, supported by new leadership, a CRA tie-up with a large private bank, mutual fund distribution launch, and near-final RBI approval for PayWorld's PPI license. Key watch points are recurring regulatory disruptions in AEPS/DMT products, Sahayak network churn (down 10% vs industry 8%), and forex margin compression, though management sees industry consolidation as a tailwind for scale players. Forward outlook hinges on H2 conversion of Q1-Q2 investments into sustainable, diversified profit growth.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for every listed Indian company
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free